Group members

Karlsson K, Rancati T, Lindbäck E, Lindberg S, Grozman V, Al-Jirf K, Lax I, Hoffmann L, Møller DS, Khalil A, Knap MM, Nielsen TB, Land LH, Kristiansen C, Ramberg C, Rogg LV, Hagen RK, Frøland AS, Drugge N, Nyman J, Josipovic M, Persson GF, Olofsson J, Bergström P, Rosenbrand HO et al. (2026)
Dose-Volume Predictors of Fatal Bronchopulmonary Bleeding After Stereotactic Body Radiation Therapy of Centrally Located Lung Tumors: An Analysis of the Expanded HILUS Cohort
Int J Radiat Oncol Biol Phys (in press)
DOI 10.1016/j.ijrobp.2025.12.007, PubMed 41532892

Garcia-Foncillas J, Bayle A, Arnold D, Avouac B, Awada A, de la Cruz-Merino L, Helland Å, Lassen U, Laurent-Puig P, Normanno N, Rohrberg K, Taieb J, Stenzinger A (2025)
Overcoming barriers to advanced biomolecular technologies that inform treatment of solid tumors: a roadmap to access
Future Oncol, 21 (14), 1745-1752
DOI 10.1080/14796694.2025.2501523, PubMed 40340714

Grønberg BH, Killingberg KT, Fløtten Ø, Bjaanæs MM, Brustugun OT, Madebo T, Langer SW, Risumlund SL, Schytte T, Helbekkmo N, Neumann K, Yksnøy Ø, Engleson J, Fluge S, Naustdal T, Giske LE, Nyman J, Tsakonas G, Halvorsen TO (2025)
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial
J Thorac Oncol, 20 (8), 1108-1119
DOI 10.1016/j.jtho.2025.04.007, PubMed 40258573